The only reason the share price is down where it is, is because management have not looked at focusing solely their energies on getting one test commercialised. The revenue from that one test would've funded everything else and that is why we have way more shares on issue with plenty more options because they didn't do this when the Sonic deal collapsed. Surely a large lab partner in the US could've been found over the last sixteen months, but no, they've pretended they can replicate Bezos and be this online behemoth.
This stock is unloved purely because of the erroneous decision making of Richard and his board. All of us thought by now we'd be selling hundreds of thousands of tests in the US with a share price in the multiple dollars, instead we're only above multi year lows and still no sign of strong revenue. Complete debacle.
PIQ Price at posting:
37.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)